Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

FOCUS ENTERTAINMENT: Capital increase reserved for employees
FOCUS ENTERTAINMENT: Capital increase reserved for employees
FOCUS ENTERTAINMENT: Capital increase reserved for employees
FOCUS ENTERTAINMENT: Announces its results for the 2023/24 financial year – a year of structuring and new organisation for the Group
FOCUS ENTERTAINMENT: Announces its results for the 2023/24 financial year – a year of structuring and new organisation for the Group
FOCUS ENTERTAINMENT: Announces its results for the 2023/24 financial year – a year of structuring and new organisation for the Group
Dassault Systèmes’ 3DEXPERIENCE Platform on the Cloud Selected by Mahindra & Mahindra as It Accelerates Its Digital Transformation: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Dassault Systèmes’ 3DEXPERIENCE Platform on the Cloud Selected by Mahindra & Mahindra as It Accelerates Its Digital Transformation


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Mahindra & Mahindra, a leader in automotive, farm and services businesses in India, is advancing its digital

Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

Verimatrix XTD Dashboard entwickelt sich weiter: Revolutionierung der Sichtbarkeit, Verfolgung und Handlungsfähigkeit von Risiken: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix XTD Dashboard entwickelt sich weiter: Revolutionierung der Sichtbarkeit, Verfolgung und Handlungsfähigkeit von Risiken


Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, hat heute wichtige Verbesserungen seines XTD-Dashboards bekannt gegeben. Damit

Verimatrix XTD Dashboard Evolves: Revolutionizing Risk Visibility, Tracking, and Actionability: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix XTD Dashboard Evolves: Revolutionizing Risk Visibility, Tracking, and Actionability


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced major enhancements to its XTD dashboard

Medidata Launches Clinical Data Studio, Leveraging AI to Modernize the Data Experience in Clinical Trials: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Medidata Launches Clinical Data Studio, Leveraging AI to Modernize the Data Experience in Clinical Trials


Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Clinical Data Studio, a unified experience

Medidata startet Clinical Data Studio und nutzt KI, um Datenumgebungen für klinische Studien zu modernisieren: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Medidata startet Clinical Data Studio und nutzt KI, um Datenumgebungen für klinische Studien zu modernisieren


Medidata, eine Marke von Dassault Systèmes und führender Anbieter von Lösungen für klinische Studien in der biowissenschaftlichen Industrie, gab heute die Einführung von Medidata Clinical Data

ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis: https://mms.businesswire.com/media/20210302005302/en/862456/5/ABIONYX_W.jpg
ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis


ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world’s only natural

GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM
GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM
GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM
GEVELOT S.A.: ANNUAL GENERAL MEETING JUNE 2024 PRESS RELEASE
GEVELOT S.A.: ANNUAL GENERAL MEETING JUNE 2024 PRESS RELEASE
GEVELOT S.A.: ANNUAL GENERAL MEETING JUNE 2024 PRESS RELEASE
Verimatrix ist Technologieführer im Report SPARK Matrix: In-App Protection, Q1 2024: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix ist Technologieführer im Report SPARK Matrix: In-App Protection, Q1 2024


Verimatrix (Euronext Paris: VMX, FR0010291245), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, ist von Quadrant Knowledge Solutions erneut als Technologieführer in

Verimatrix Named a Technology Leader in SPARK Matrix: In-App Protection Q1 2024 Report: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix Named a Technology Leader in SPARK Matrix: In-App Protection Q1 2024 Report


Regulatory News:



Verimatrix, (Euronext Paris: VMX, FR0010291245), the leader in powering the modern connected world with people-centered security, today announced it was once again named a

Valeo Partners With Dassault Systèmes to Accelerate the Digitalization of Its R&D: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Valeo Partners With Dassault Systèmes to Accelerate the Digitalization of Its R&D


Valeo, a world leader in mobility technologies, and Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced their partnership. Valeo will rely on Dassault Systèmes’ “Global Modular

Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg
Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024


Regulatory News:



Median Technologies (Paris:ALMDT):


Total number of shares


18,418,233


Number of real voting rights* (excluding treasury shares**)


18,373,987

Verimatrix XTD Accessibility Abuse Detector™ bietet erweiterten Schutz für Android-Apps: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix XTD Accessibility Abuse Detector™ bietet erweiterten Schutz für Android-Apps


Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute die allgemeine Verfügbarkeit seines Verimatrix XTD Accessibility Abuse

Verimatrix XTD Accessibility Abuse Detector™ Brings Expanded Android App Protections: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix XTD Accessibility Abuse Detector™ Brings Expanded Android App Protections


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the general availability of its Verimatrix

Verimatrix präsentiert neueste Innovationen zur Sicherheit mobiler Apps auf der droidcon in San Francisco und Berlin: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix präsentiert neueste Innovationen zur Sicherheit mobiler Apps auf der droidcon in San Francisco und Berlin


Regulatorische Nachrichten:



Verimatrix, (Euronext Paris: VMX, FR0010291245), das führende Unternehmen im Bereich der modernen vernetzten Welt mit menschenzentrierter Sicherheit, gab heute

VERIMATRIX gibt die Aufnahme der Berichterstattung über seine Aktie durch Portzamparc bekannt: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
VERIMATRIX gibt die Aufnahme der Berichterstattung über seine Aktie durch Portzamparc bekannt


Regulatorische Nachrichten:



Verimatrix (Euronext Paris: VMX, FR0010291245), das führende Unternehmen im Bereich der modernen vernetzten Welt mit menschenzentrierter Sicherheit, gibt heute die

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
GenSight Biologics to Present at Upcoming Medical Conferences and Stakeholder Meetings: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics to Present at Upcoming Medical Conferences and Stakeholder Meetings


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

VERIMATRIX Announces the Initiation of Coverage of Its Stock by Portzamparc: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
VERIMATRIX Announces the Initiation of Coverage of Its Stock by Portzamparc


Regulatory News:



VERIMATRIX (Euronext Paris: VMX, FR0010291245), the leader in powering the modern connected world with people-centered security, today is pleased to announce the initiation of

Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 19, 2024: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 19, 2024


Regulatory News:



The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) are invited to participate in the Shareholders’ Ordinary and

Verimatrix To Highlight Latest Mobile App Security Innovations at droidcon San Francisco and Berlin: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix To Highlight Latest Mobile App Security Innovations at droidcon San Francisco and Berlin


Regulatory News:



Verimatrix, (Euronext Paris: VMX, FR0010291245), the leader in powering the modern connected world with people-centered security, today announced it’s scheduled to exhibit